跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MORPHINE SULFATE INJECTION EPIDURAL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MORPHINE SULFATE INJECTION EPIDURAL
Authorized
STANDARD
MORPHINE SULFATE INJECTION EPIDURAL
Sterimax Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6603956bd4e24df4
Company
Sterimax Inc
Type
Standard
Approval Details
Approval Id
6603956bd4e24df4
Drug Approval Canada Name
MORPHINE SULFATE INJECTION EPIDURAL
Product Name
MORPHINE SULFATE INJECTION EPIDURAL
Status
Marketed
Status Date
2021-05-21
Original Market Date
2021-05-21
Din
02498278
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Epidural
Schedule
Narcotic (CDSA I)
Ahfs
28:08.08
Atc Original
N02AA01 MORPHINE
Atc Name
n 02 aa 01
Aig Number
0104545007
Company Name
Sterimax Inc
Company Address
2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4
Active Ingredients
MORPHINE SULFATE
0.5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6603956bd4e24df4
Type
Standard
Back to Health Canada Approvals